Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Kotak Mahindra Bank appoints Ramesh Iyer as Independent Director; Ashok Gulati to retire in March
Kotak Mahindra Bank appoints Ramesh Ganesh Iyer as Independent Director from February 17, 2026, succeeding Dr. Ashok Gulati. Iyer brings vast Mahindra Group experience and multiple industry awards.
Nifty recovers 200 points from intra-day lows; IT continues outperformance | Closing Bell
Indian equities erased all the intraday losses with Nifty back above 23,500. TCS, Infosys, HCL Tech, Tech Mahindra, Trent are among top gainers on the Nifty, while losers are NTPC, Power Grid Corp, Cipla, Dr Reddy's Labs and L&T. Among sectors IT index up 4%, while auto, metal, Consumer Durables, realty up 0.5% each. However, pharma, healthcare, power, media, energy down 0.5-1%. Nifty Midcap and Smallcap indices down marginally. Catch Lovish Darad in conversation with Market Experts.
Stocks to Watch Today: Kotak Bank, Torrent Power, Persistent, Aurobindo Pharma, Dr Reddys Labs, KEC International, Turtlemint, Transrail, Airtel in focus on 29 June
Stocks to Watch, 29 Jun: Stocks like Kotak Mahindra Bank, Torrent Power, Persistent Systems, Aurobindo Pharma, Indoco Remedies, BEML, Lupin, Dr Reddys Laboratories, Jubilant Pharmova, Zydus Lifesciences, Hexaware Technologies, KEC International, Bharti Airtel, and Vodafone Idea will be in focus on June 29.
Buy Kotak Mahindra Bank; target of Rs 480: ICICI Securities
ICICI Securities is bullish on Kotak Mahindra Bank has recommended buy rating on the stock with a target price of Rs 480 in its research report dated May 31, 2026.
Taking Stock: Sensex, Nifty extend gains on 3rd day; rupee sinks to fresh low
Biggest Nifty gainers were Jio Financial, Tech Mahindra, Infosys, Eternal, M&M, while losers included Coal India, NTPC, HUL, Cipla and Sun Pharma.
Taking Stock: Markets snap 2-day fall; Sensex up 395 pts, Nifty above 23,200
Biggest Nifty gainers were Interglobe Aviation, Jio Financial, Eicher Motors, SBI, Apollo Hospitals, while losers included ONGC, Titan Company, NTPC, Power Grid Corp and Tech Mahindra.
Stocks to Watch Today: Kotak Bank, KPIT Tech, Waterways Leisure, Advit Jewels, Genus Power, Ivalue Info, Cupid, RailTel, Rane Madras in focus on 01 July
Stocks to Watch, 01 Jul: Stocks like KPIT Technologies, Cupid, Hexagon Nutrition, Kotak Mahindra Bank, RailTel Corporation of India, Tata Communications, Rane Madras, RHI SRF, Genus Power Infrastructures, Indo Tech Transformers, Ivalue Infosolutions, and Axiscades Technologies will be in focus on July 1.
Closing Bell: Day 2 of gains pushes Nifty above 23,550, Sensex up 568 pts led by auto, metal, realty
Nifty midcap index rose 1 percent, while smallcap index added 0.65 percent. Eternal, Tata Steel, M&M, HDFC Life and Bharat Electronics were among top gainers on the Nifty, while losers were Wipro, Tata Consumer, Infosys, Cipla, ITC. Among sectors, except FMCG ( down 0.7%) and IT (down 1%), all other indices ended in the green with capital goods, telecom, auto, infra, media, metal, realty, private bank up 1-2 percent.
Taking Stock: Markets extend losses; Nifty slips below 24,200, Sensex declines 852 pts
Biggest Nifty losers were Trent, M&M, Shriram Finance, SBI Life Insurance, Tech Mahindra, while gainers included Dr Reddy's Labs, Cipla, Jio Financial, Adani Enterprises, Apollo Hospitals.
Closing Bell: Market snaps 3-day fall; Nifty above 23,400, Sensex surges 939 pts
Biggest Nifty gainers M&M, Grasim Industries, Trent, UltraTech Cement, Bajaj Finance, while losers are Bharat Electronics, Wipro, Max Healthcare, Sun Pharma, Coal India. On the sectoral front, auto, bank, FMCG up 0.5-1%, while media, oil & gas, pharma, realty, capital goods down 0.5-2%. Nifty Midcap index is trading flat, while smallcap index down 0.5%.
Buy Kotak Mahindra Bank; target of Rs 480: ICICI Securities
ICICI Securities is bullish on Kotak Mahindra Bank has recommended buy rating on the stock with a target price of Rs 480 in its research report dated May 03, 2026.
Kotak Mahindra MF buys Rs 612 crore worth Emcure shares from Bain Capital, promoter sells 2.8% stake in Ajanta Pharma
BC Investments held 3.87 percent stake in Emcure Pharmaceuticals as of March 2026.